We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...
GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from ...
In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...
Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...
UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...
Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...
With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmithKline's venerable vaccine Priorix for sale in the US looks timely. Priorix was first launched in Europe ...
UnitedHealth CEO Andrew Witty said on Thursday that healthcare in the U.S. needs to be "less confusing, less complex and less ...
The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...